Latest Regulatory News

Trigg Minerals is advancing its strategy to list on the U.S. NASDAQ, weighing options including a dual listing and potential SPAC mergers, while planning a name change to reflect its evolving focus.

Artrya Limited has successfully navigated a key FDA Q-Submission meeting, receiving clear guidance on the regulatory pathway for its Salix Coronary Flow module, with a 510(k) submission planned by year-end.

Toubani Resources has locked in a comprehensive A$395 million funding package, fully financing the development of its Kobada Gold Project in Mali and positioning itself as a future high-margin West African gold producer.

Equity Story Group has terminated its acquisition agreement with Baker Young Limited after failing to meet key conditions by the September deadline, signaling a strategic pivot for the financial services firm.

Toubani Resources has locked in a transformative A$395 million funding package to advance its Kobada Gold Project in Mali, setting the stage for production to commence by the third quarter of 2027.

Pacgold Limited’s trading suspension has been lifted following its announcement of a capital raising, signaling renewed market activity for the gold explorer.

NSX Limited shareholders overwhelmingly approved a scheme of arrangement for acquisition by 1001290557 Ontario Inc., a related entity of the Canadian Stock Exchange operator CNSX Markets Inc. The deal, valued at four cents per fully paid share, now awaits Federal Court approval to proceed.

DigitalX Limited reveals a robust A$101 million treasury portfolio dominated by Bitcoin holdings and a significant cash increase from Solana sales, underpinning its ambitious target of accumulating 2,100 Bitcoins by 2027.

Buru Energy secured key government approvals and identified a promising new gas prospect beneath its Rafael field, while raising $4.4 million to fund development activities. The company is gearing up for a Final Investment Decision in 3Q 2026, aiming for first material cash flow by 2028.

Triangle Energy and its joint venture partners have been awarded two offshore service contracts in the underexplored Sandakan Basin, Philippines, holding significant contingent gas and condensate resources. These contracts mark a strategic expansion into a promising region with multi-TCF exploration upside.

Kingsgate Consolidated updates its 2025 Mineral Resources and Ore Reserves, introducing a maiden estimate for the Chatree South-East Complex while reporting modest declines in overall Ore Reserves.

Prescient Therapeutics has bolstered its cash reserves to $12.3 million following a $9.8 million capital raise, while progressing its PTX-100 cancer therapy through global Phase 2 trials with encouraging early lymphoma results.